HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Endogenous IFN-β maintains M1 polarization status and inhibits proliferation and invasion of hepatocellular carcinoma cells].

Abstract
Objective To investigate the effect of endogenous interferon β (IFN-β) on the polarization of M1 macrophages as well as the proliferation and invasion activities of hepatocellular carcinoma cells (HCCs) mediated by M1 macrophages. Methods U937-M1 macrophages derived from human monocytic tumor cells U937 was established and the cell phenotypes were identified by real-time quantitative PCR, ELISA and flow cytometry. After IFN-β gene was knocked down with siRNA or IFN-β was neutralized with IFN-β monoantibody in U937-M1 macrophages, the change of M1/M2 phenotype was again analyzed by the above methods. The expressions of interferon regulatory factor 1 (IRF1) and IRF5 were detected by real-time quantitative PCR and Western blotting. The proliferation and invasion activities of HCCs, which were cultured with conditioned medium (CM) collected from different macrophage groups, were analyzed by CCK-8 assay and Transwell(TM) experiments, respectively. Results U937-M1 macrophages showed higher expressions of interleukin 12p35 (IL-12p35), interleukin 12p40 (IL-12p40), interleukin 12p70 (IL-12p70), interleukin 23p19 (IL-23p19), interleukin 6 (IL-6), tumor necrosis factor α (TNF-α) and CD86 than U937-M0 did. But both U937-M0 macrophages and U937-M1 macrophages showed low expression of CD206. However, compared with the U937-M1 macrophages, the IFN-β-blocked U937-M1 macrophages presented decreased expressions of the above M1 macrophages-associated markers, but increased expressions of M2 macrophages-associated markers IL-10 and CD206, as well as lower expressions of IRF1 and IRF5. The inhibited proliferation/invasion activities of HCCs mediated by U937-M1 macrophages were reversed by IFN-β-blocked U937-M1 macrophages. Conclusion Blocking endogenous IFN-β could inhibit the U937-M1 polarization status and U937-M1 macrophages-mediated anti-tumor activity of HCCs. IFN-β might be involved in modulating the expressions of IRF1 and IRF5 as well as maintaining the M1 polarization status and its function.
AuthorsChangli Xie, Bianqin Guo, Cuiying Liu, Yan Lin, Bitao Wu, Qin Wang, Ziwei Li, Zhiguang Tu
JournalXi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology (Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi) Vol. 32 Issue 7 Pg. 865-9 (Jul 2016) ISSN: 1007-8738 [Print] China
PMID27363262 (Publication Type: Journal Article)
Chemical References
  • Culture Media, Conditioned
  • IRF5 protein, human
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factors
  • Interleukin-23
  • Lectins, C-Type
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Receptors, Cell Surface
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-12
  • Interferon-beta
Topics
  • Blotting, Western
  • Carcinoma, Hepatocellular (pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival (drug effects)
  • Culture Media, Conditioned (pharmacology)
  • Flow Cytometry
  • Hep G2 Cells
  • Humans
  • Interferon Regulatory Factor-1 (genetics, metabolism)
  • Interferon Regulatory Factors (genetics, metabolism)
  • Interferon-beta (genetics, metabolism)
  • Interleukin-10 (genetics, metabolism)
  • Interleukin-12 (genetics, metabolism)
  • Interleukin-23 (genetics, metabolism)
  • Lectins, C-Type (genetics, metabolism)
  • Liver Neoplasms (pathology)
  • Macrophage Activation
  • Macrophages (classification, metabolism)
  • Mannose Receptor
  • Mannose-Binding Lectins (genetics, metabolism)
  • Neoplasm Invasiveness
  • RNA Interference
  • Receptors, Cell Surface (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: